Данилова Олеся Евгеньевна
Ministry of Health of the Russian Federation · 39 works · 41 citations · h-index 3
Top works
- Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril
- CARDIOTOXICITY AND METHODS OF ITS DIAGNOSIS IN HEMATOLOGY PATIENTS (REVIEW)
- Endothelial dysfunction in patients with lymphoproliferative disorders and its changes in the course of polychemotherapy
- Diagnostic capabilities of instrumental methods for studying early cardiovascular adverse events in patients with lymphoproliferative disorders, quality and safety issues
- ATYPICAL HEMOLYTIC UREMIC SYNDROME: A CASE STUDY
- Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin’s Lymphomas in the Course of Programmatic Antitumor Therapy
- MICROCIRCULATORY FEATURES IN PATIENTS WITH NEWLY DIAGNOSED INDOLENT NON-HODGKIN'S LYMPHOMA WITH A HISTORY OF CARDIOVASCULAR COMPLICATIONS
- Cardiovascular toxicity in patients with oncohematological diseases: genetic predictors study
- Cardiovascular Toxicity of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia
- FEATURES OF HEMOSTASIS IN ONCOHEMATOLOGICAL PATIENTS WHO HAVE UNDERGONE COVID-19 (LITERATURE REVIEW)
- Current Aspects in Early Diagnosis of Cardiotoxic Complications of Drug Therapy in Oncology: A Literature Review
- CHRONIC GASTRITIS AND FUNCTIONAL DYSPEPSIA: CURRENT ISSUES IN CLASSIFICATION, DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS IN THE CONTEXT OF THE KYOTO GLOBAL CONSENSUS.
- Genetic polymorphisms associated with the development of arrhythmic type of cardiovascular events
- Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease
- Genetic risk factors: the influence on the cardiovascular toxicity in patients with lymphoproliferative diseases
- Markers Determining the Risk of Cardiovascular Toxicity Against the Background of Antitumor Immunochemotherapy
- Genetic predictors of cardiovascular toxicity in oncohematological patients
- Optimization of the diagnosis of cardiovascular adverse events in patients with non-Hodgkin lymphomas
- Неходжкинские лимфомы у ВИЧ-инфицированных больных на фоне ВААРТ
- Феррицианидредуктуза и ацетилхолинэстераза эритроцитов как маркеры велоэргометрической пробы в диагностике стенокардии у больных постинфарктным кардиосклерозом